Search research articles
Contact Us
Filters
Showing results (191-200 of 280) with videos related to
Page
of 28
Sort By:
Clinical and Translational Medicine
|
December 30, 2020
A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity
Yueqi Chen, Wenhui Hu, Yiran Wang, et al.
European Journal of Pharmacology
|
July 22, 2022
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice
Shuli Liang, Zhongjin Yang, Lei Hua, et al.
BMC Medical Genomics
|
September 12, 2018
Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling
Yonggang Zhang, Gustavo Arango, Fang Li, et al.
European Journal of Medicinal Chemistry
|
August 7, 2025
Discovery of novel 8-hydroxyquinoline derivatives as NLRP3 inflammasome inhibitors with therapeutic potential for inflammatory bowel disease
Xiuxiu Zhang, Ruiwen Wu, Yuyun Yan, et al.
Chemmedchem
|
June 20, 2020
Discovery of an Orally Active and Long-Acting DPP-IV Inhibitor through Property-Based Optimization with an in Silico Biotransformation Prediction Tool
Shaogao Zeng, Wenyuan Dou, Manna Li, et al.
European Journal of Medicinal Chemistry
|
March 12, 2025
Discovery, synthesis, and biological mechanism evaluation of novel quinoline derivatives as potent NLRP3 inhibitors
Ruiwen Wu, Yuyun Yan, Zhuorong Liu, et al.
European Journal of Medicinal Chemistry
|
April 12, 2021
Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities
Cheng Zhang, Hu Yue, Ping Sun, et al.
Biochemical Pharmacology
|
November 3, 2022
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation
Xiuhui Chen, Yanhong Chen, Yitao Ou, et al.
Antiviral Research
|
September 18, 2012
Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors
Xin Zhao, Yanling Jie, Matthew R Rosenberg, et al.
European Journal of Medicinal Chemistry
|
September 3, 2013
Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization
Hui Xie, Lili Zeng, Shaogao Zeng, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 280) with videos related to
Sort By:
Page
of 28
Clinical and Translational Medicine
|
December 30, 2020
A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity
Yueqi Chen, Wenhui Hu, Yiran Wang, et al.
European Journal of Pharmacology
|
July 22, 2022
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice
Shuli Liang, Zhongjin Yang, Lei Hua, et al.
BMC Medical Genomics
|
September 12, 2018
Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling
Yonggang Zhang, Gustavo Arango, Fang Li, et al.
European Journal of Medicinal Chemistry
|
August 7, 2025
Discovery of novel 8-hydroxyquinoline derivatives as NLRP3 inflammasome inhibitors with therapeutic potential for inflammatory bowel disease
Xiuxiu Zhang, Ruiwen Wu, Yuyun Yan, et al.
Chemmedchem
|
June 20, 2020
Discovery of an Orally Active and Long-Acting DPP-IV Inhibitor through Property-Based Optimization with an in Silico Biotransformation Prediction Tool
Shaogao Zeng, Wenyuan Dou, Manna Li, et al.
European Journal of Medicinal Chemistry
|
March 12, 2025
Discovery, synthesis, and biological mechanism evaluation of novel quinoline derivatives as potent NLRP3 inhibitors
Ruiwen Wu, Yuyun Yan, Zhuorong Liu, et al.
European Journal of Medicinal Chemistry
|
April 12, 2021
Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities
Cheng Zhang, Hu Yue, Ping Sun, et al.
Biochemical Pharmacology
|
November 3, 2022
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation
Xiuhui Chen, Yanhong Chen, Yitao Ou, et al.
Antiviral Research
|
September 18, 2012
Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors
Xin Zhao, Yanling Jie, Matthew R Rosenberg, et al.
European Journal of Medicinal Chemistry
|
September 3, 2013
Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization
Hui Xie, Lili Zeng, Shaogao Zeng, et al.
Page
of 28